Nuvation Common Stock Shares Outstanding vs Warrants Analysis
| NUVB Stock | USD 2.89 0.09 3.21% |
Nuvation Bio financial indicator trend analysis is infinitely more than just investigating Nuvation Bio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nuvation Bio is a good investment. Please check the relationship between Nuvation Bio Common Stock Shares Outstanding and its Warrants accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.
Common Stock Shares Outstanding vs Warrants
Common Stock Shares Outstanding vs Warrants Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nuvation Bio Common Stock Shares Outstanding account and Warrants. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Nuvation Bio's Common Stock Shares Outstanding and Warrants is -0.14. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Warrants in the same time period over historical financial statements of Nuvation Bio, assuming nothing else is changed. The correlation between historical values of Nuvation Bio's Common Stock Shares Outstanding and Warrants is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Nuvation Bio are associated (or correlated) with its Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Warrants has no effect on the direction of Common Stock Shares Outstanding i.e., Nuvation Bio's Common Stock Shares Outstanding and Warrants go up and down completely randomly.
Correlation Coefficient | -0.14 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Warrants
Securities that give the holder the right to purchase a company's stock at a specified price before a certain date. Warrants are similar to options but are typically issued directly by the company.Most indicators from Nuvation Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nuvation Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.As of November 27, 2024, Selling General Administrative is expected to decline to about 22.1 M. In addition to that, Enterprise Value Over EBITDA is expected to decline to -3.08
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 3.0M | 7.4M | 24.6M | 25.8M | Net Interest Income | 3.0M | 7.4M | 24.6M | 25.8M |
Nuvation Bio fundamental ratios Correlations
Click cells to compare fundamentals
Nuvation Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nuvation Bio fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Current Liabilities | 3.2M | 6.6M | 16.9M | 13.2M | 14.0M | 10.0M | |
| Net Tangible Assets | (24.1M) | (52.4M) | 746.0M | 655.1M | 753.3M | 791.0M | |
| Retained Earnings | (34.3M) | (76.0M) | (162.8M) | (267.0M) | (342.8M) | (325.7M) | |
| Accounts Payable | 2.0M | 2.2M | 3.9M | 2.1M | 2.2M | 2.3M | |
| Total Current Assets | 119.9M | 220.7M | 772.1M | 667.3M | 616.4M | 439.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Nuvation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nuvation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nuvation Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nuvation Bio Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.18) | Revenue Per Share 0.009 | Return On Assets (0.14) | Return On Equity (0.96) |
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.